MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 8081-8090 Newer>
The Motley Fool
November 25, 2011
Brian Orelli
7 Black Friday Biotech Bargains Get in at the right time to maximize your returns. mark for My Articles 522 similar articles
The Motley Fool
November 25, 2011
A Brief History of Eli Lilly's Returns The good news is that, with shares now trading at around 10 times earnings, Eli Lilly looks reasonably valued, if not cheap. mark for My Articles 387 similar articles
The Motley Fool
November 25, 2011
Dan Caplinger
Has Merck Become the Perfect Stock? Like most other pharma companies, Merck is dealing with the imminent loss of patent protection on one of its blockbuster drugs. mark for My Articles 923 similar articles
The Motley Fool
November 23, 2011
Brian Orelli
I Was Wrong About Dendreon But maybe not in the long term. mark for My Articles 246 similar articles
The Motley Fool
November 22, 2011
Brian Orelli
This Spec Pharma Hopes Convenience Trumps All Spectrum Pharmaceuticals' Zevalin no longer requires a bioscan. mark for My Articles 56 similar articles
The Motley Fool
November 22, 2011
Brian Orelli
A Little Diversity Goes a Long Way Especially in this economy. mark for My Articles 175 similar articles
The Motley Fool
November 22, 2011
Luke Timmerman
Pfizer Acquires Excaliard, an Isis Spinout With Drug to Fight Excessive Scarring Pfizer is making a new bet on a new drug to fight excessive scarring. mark for My Articles 122 similar articles
The Motley Fool
November 22, 2011
Selena Maranjian
Make Money in Global Health-Care Stocks the Easy Way If you expect the global health-care industry to thrive as our planet's population grows and ages, the iShares S&P Global Health Care ETF could save you a lot of trouble. mark for My Articles 882 similar articles
The Motley Fool
November 21, 2011
David Williamson
Market Volatility = Biotech Opportunity Gilead buys Pharmasset, Spectrum gets a break, and Eylea's approved. mark for My Articles 156 similar articles
Fast Company
November 19, 2011
Tristram Korten
Cracking Down On $70 Billion Worth Of Medicare Fraud A pharmacy run out of this storefront near Miami billed a federal agency for $776,298 - in just nine days. There were no real employees. There were no real patients. There were no real prescriptions. How medical fraud has become an untreated epidemic. mark for My Articles 153 similar articles
<Older 8081-8090 Newer>    Return to current articles.